Investor

We Venture Capital

·Barcelona ·Multi stage ·Actively investing

We Venture Capital is the corporate venture capital arm of Werfen, a global leader in specialized diagnostics. It invests worldwide in diagnostics, digital health, and life science tools start-ups, primarily at Series A with selective Seed and Series B checks, using an evergreen fund structure and active board engagement.

Portfolio

Team

AUM

n/a

Rounds

SectorsDiagnostics, Digital Health, Life Science Tools VC MapCorporate VC

Profile updated 18 Jul 2026

Team

Partners 0 Investment Team 3 Others 1

Anthony Vallance-Owen

Senior Investment Manager

Gemma Sturt

Senior Investment Manager

Gokce Gun

Investment Analyst

—

Portfolio companies 1

deepull

deepull.com

Company Series C Barcelona

Funding rounds 1

deepull · Series C · €50M

Barcelona-based medtech deepull closed an oversubscribed €50 million Series C co-led by Columbus Venture Partners, Panakès Partners and Méri…

2025-04-29

News & media 8

Published	Article
2026-04-07	TriNetX Acquires Zetta Genomics Assets ↗ GenomeWeb
2025-07-24	Singapore's Respiree closes $11.6M Series A financing round led by We Venture Capital and ClavystBio ↗ TNGlobal (Technode Global)
2025-06-30	Portal Biotech lands NATO Innovation Fund first biotech investment ↗ Vestbee
2025-01-09	Doctor-led Oxford Cancer Analytics closes $16-million CAD Series A to improve early lung cancer detection ↗ BetaKit
2025-01-02	Proton Intelligence Raises $6.95M in Seed Funding ↗ FinSMEs
2024-02-15	Capitainer Secures SEK 30 Million Investment from We Venture Capital to Expand and Innovate in Self-Sampling Solutions ↗ Cision (Capitainer AB press release)
2024-02-08	Zetta Genomics secures additional £1.8M in seed funding for genomic data analysis platform ↗ Tech.eu
2023-09-08	Werfen Launches Corporate VC Arm ↗ FinSMEs